DK1265480T3 - Kimærisk forsøgsdyr, der er modtageligt over for infektion med human hepatitis C-virus - Google Patents

Kimærisk forsøgsdyr, der er modtageligt over for infektion med human hepatitis C-virus

Info

Publication number
DK1265480T3
DK1265480T3 DK01914893.1T DK01914893T DK1265480T3 DK 1265480 T3 DK1265480 T3 DK 1265480T3 DK 01914893 T DK01914893 T DK 01914893T DK 1265480 T3 DK1265480 T3 DK 1265480T3
Authority
DK
Denmark
Prior art keywords
human
agents
chimeric
virus infection
human hepatitis
Prior art date
Application number
DK01914893.1T
Other languages
English (en)
Inventor
Norman M Kneteman
Lorne D Tyrrell
David F Mercer
Original Assignee
Kmt Hepatech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kmt Hepatech Inc filed Critical Kmt Hepatech Inc
Application granted granted Critical
Publication of DK1265480T3 publication Critical patent/DK1265480T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK01914893.1T 2000-03-17 2001-03-16 Kimærisk forsøgsdyr, der er modtageligt over for infektion med human hepatitis C-virus DK1265480T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/528,120 US6509514B1 (en) 2000-03-17 2000-03-17 Chimeric animal model susceptible to human hepatitis C virus infection
PCT/CA2001/000350 WO2001067854A1 (en) 2000-03-17 2001-03-16 Chimeric animal model susceptible to human hepatitis c virus infection

Publications (1)

Publication Number Publication Date
DK1265480T3 true DK1265480T3 (da) 2010-09-20

Family

ID=24104337

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01914893.1T DK1265480T3 (da) 2000-03-17 2001-03-16 Kimærisk forsøgsdyr, der er modtageligt over for infektion med human hepatitis C-virus

Country Status (13)

Country Link
US (6) US6509514B1 (da)
EP (1) EP1265480B1 (da)
JP (2) JP4059672B2 (da)
KR (1) KR100656795B1 (da)
AT (1) ATE469547T1 (da)
AU (2) AU4216301A (da)
CA (1) CA2402117C (da)
DE (1) DE60142281D1 (da)
DK (1) DK1265480T3 (da)
ES (1) ES2346636T3 (da)
IL (2) IL151621A0 (da)
NZ (1) NZ521119A (da)
WO (1) WO2001067854A1 (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995299B2 (en) * 1999-11-02 2006-02-07 University Of Connecticut Propagation of human hepatocytes in non-human animals
US6509514B1 (en) * 2000-03-17 2003-01-21 Kmt Hepatech, Inc. Chimeric animal model susceptible to human hepatitis C virus infection
JPWO2002028174A1 (ja) * 2000-10-03 2004-02-12 財団法人 東京都医学研究機構 Ｃ型肝炎ウイルス感染方法
US20030096316A1 (en) * 2001-11-21 2003-05-22 Ingmar Wester Use of apolipoprotein B as a single marker for evaluation of the risk or cardiovascular disease
JP4907843B2 (ja) * 2002-03-25 2012-04-04 公益財団法人ひろしま産業振興機構 ヒト肝細胞増殖方法とヒト肝細胞の取得方法
EP1552740A1 (en) * 2004-01-09 2005-07-13 Institut Pasteur Chimeric murine model comprising human hepatocytes - use for screening compounds
AU2005277463A1 (en) * 2004-08-20 2006-03-02 Kmt Hepatech, Inc. Malarial animal model having a chimeric human liver
EP1801582B1 (en) * 2004-08-20 2010-03-17 Sekisui Medical Co., Ltd. Method of predicting the metabolism of drug in human liver and liver function
WO2006021896A2 (en) 2004-08-27 2006-03-02 Tripep Ab Transgenic mouse models of hepatitis c virus (hcv) and identification of hcv therapeutics
CA2587886A1 (en) * 2004-11-16 2006-05-26 Hiroshima Industrial Promotion Organization Method of screening candidate drug
US20060147429A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Facilitated cellular reconstitution of organs and tissues
US20060148080A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Methods for supporting and producing human cells and tissues in non-human mammal hosts
EP1909564A4 (en) * 2005-07-18 2010-06-30 Novartis Ag SMALL ANIMAL MODEL FOR HCV REPLICATION
US8569573B2 (en) * 2007-06-05 2013-10-29 Oregon Health & Science University Method of expanding human hepatocytes in vivo
US9173383B2 (en) * 2008-02-21 2015-11-03 The University Of North Carolina At Chapel Hill Recombinant non-human mammalian model for hepatitis infection and immunopathogenesis
CN101550425B (zh) * 2008-03-31 2011-03-30 北京大学 一种可调控的肝损伤动物模型的制作方法及其专用载体
JP5710097B2 (ja) * 2008-07-10 2015-04-30 株式会社バイオマーカーサイエンス 動脈硬化改善・予防効果の評価方法、物質のスクリーニング方法、並びに、マーカーとしての使用
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US9186128B2 (en) * 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
CN101748123B (zh) * 2008-11-27 2012-11-07 北京大学 可调控肝损伤动物模型的制作方法及其专用dna片段
CN102281758B (zh) * 2009-01-16 2014-12-10 公益财团法人实验动物中央研究所 移植了人肝细胞的小鼠
JP5841322B2 (ja) 2010-04-22 2016-01-13 オレゴン ヘルス アンド サイエンス ユニバーシティ フマリルアセト酢酸ヒドロラーゼ（ｆａｈ）欠損性ブタおよびその使用
US10004826B2 (en) 2010-10-06 2018-06-26 Massachusetts Institute Of Technology Implantable human liver tissue constructs and uses thereof
EP2747551B1 (en) 2011-08-26 2020-02-12 Yecuris Corporation Fumarylacetoacetate hydrolase (fah)-deficient and immunodeficient rats and uses thereof
JP5950235B2 (ja) 2011-09-30 2016-07-13 公立大学法人横浜市立大学 肝細胞の分化誘導方法、ヒト化肝臓キメラ非ヒト動物の作製方法
JP5883265B2 (ja) * 2011-10-13 2016-03-09 株式会社フェニックスバイオ ヒト肝細胞を担持するキメラ非ヒト動物
CN104160272A (zh) * 2011-12-06 2014-11-19 麻省理工学院 利用人源化的小鼠来确定毒性
AU2012374750B2 (en) * 2012-03-27 2017-02-02 National University Corporation Kumamoto University Humanized mouse
JP5976380B2 (ja) 2012-04-27 2016-08-23 公益財団法人東京都医学総合研究所 ウロキナーゼ型プラスミノーゲンアクチベータートランスジェニックマウス
CA2878404A1 (en) 2012-07-10 2014-01-16 The Trustees Of The University Of Pennsylvania Biomaterials for enhanced implant-host integration
CN103088106A (zh) * 2013-01-25 2013-05-08 中国水产科学研究院淡水渔业研究中心 用鱼原代肝细胞损伤模型筛选鱼类保肝药物的方法
WO2015073222A1 (en) 2013-11-01 2015-05-21 Oregon Health & Science University Normalization of the enterohepatic circulation in animals with a chimeric humanized liver
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
US11338065B2 (en) 2015-10-08 2022-05-24 Massachusetts Institute Of Technology In situ expansion of engineered devices for regeneration
CN106047870B (zh) * 2016-06-16 2019-01-08 中国医学科学院医学生物学研究所 树鼩mhc-drb1*1101基因序列及其应用
TWI767916B (zh) 2016-06-27 2022-06-21 美國貝勒醫學院 具缺陷p450氧化還原酶之人類肝嵌合非人類動物及其使用方法
CA3051442A1 (en) 2017-02-14 2018-08-23 Alejandro Soto-Gutierrez Methods of engineering human induced pluripotent stem cells to produce liver tissue
WO2019059851A1 (en) * 2017-09-25 2019-03-28 National University Of Singapore CHIMERIC ANIMAL COMPRISING STABLE TRANSPLANTED BATTERY CELLS
KR102362814B1 (ko) 2020-06-04 2022-02-15 한국생명공학연구원 인간 간세포 이식용 동물모델 및 이를 이용한 항바이러스제 스크리닝 방법

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476996A (en) * 1988-06-14 1995-12-19 Lidak Pharmaceuticals Human immune system in non-human animal
US5994617A (en) * 1988-09-19 1999-11-30 Hsc Research Development Corporation Engraftment of immune-deficient mice with human cells
US5849288A (en) 1990-01-15 1998-12-15 Yeda Research And Development Co. Ltd. Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
DK0438053T3 (da) 1990-01-15 1999-11-22 Yeda Res & Dev Varig transplantation og udvikling af humane hæmopoietiske cellelinjer i normale pattedyr
US5652373A (en) 1990-01-15 1997-07-29 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
US5858328A (en) 1991-06-04 1999-01-12 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5849987A (en) 1992-06-02 1998-12-15 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5804160A (en) 1991-06-04 1998-09-08 Yeda Research And Development Co. Ltd Animal model for hepatitis virus infection
US5408038A (en) 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
US5866757A (en) 1992-06-02 1999-02-02 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
IL106368A0 (en) 1992-07-24 1993-11-15 Univ Pennsylvania Non-native liver generation in an animal with impaired native liver function,by cell implantation
EP0699235B1 (en) 1993-05-17 2007-05-09 Yeda Research And Development Company, Ltd. Animal model for hepatitis virus infection
US5980886A (en) * 1994-12-14 1999-11-09 University Of Washington Recombinant vectors for reconstitution of liver
US6107027A (en) 1994-12-14 2000-08-22 University Of Washington Ribozymes for treating hepatitis C
AU6222996A (en) 1995-06-07 1996-12-30 Novartis Ag Human hepatocellular tissue in chimeric immunocompromised an imals
DE69734557T2 (de) * 1996-03-15 2006-07-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Sprühvorrichtung zum aufbringen von gewebeklebstoff
GB9705744D0 (en) 1997-03-20 1997-05-07 Davies Alison M Methods for selecting cells and their uses
US6034297A (en) * 1997-09-26 2000-03-07 Cedars-Sinai Medical Center In vivo, animal model for expression of hepatitis C virus
EP1062512A4 (en) 1998-03-10 2001-12-12 Univ California METHODS AND TOOLS USED TO IDENTIFY COMPOUNDS THAT MODULATE ATHEROSCLEROSIS BY ALTERATION OF THE LDL-PROTEOGLYCANE BINDING
CA2343084A1 (en) 1998-09-18 2000-03-30 Albert Einstein College Of Medicine Of Yeshiva University Upa/rag-2 mouse with mammalian repopulating hepatocytes for infection by hepadnaviruses
US6864402B1 (en) * 1998-09-18 2005-03-08 Albert Einstein College Of Medicine Of Yeshiva University Chronic hepatitis virus infection and clonal hepatocellular carcinoma in mouse repopulated livers
US6249089B1 (en) * 1998-10-09 2001-06-19 Frederick Bruwer Intelligent electrical device comprising microchip
US6660905B1 (en) * 1999-07-14 2003-12-09 The Board Of Trustees Of The Leland Stanford Junior University Mice comprising engrafted functional human hepatocytes
US6525242B1 (en) 1999-11-02 2003-02-25 The University Of Connecticut Propagation of human hepatocytes in non-human mammals
US6509514B1 (en) 2000-03-17 2003-01-21 Kmt Hepatech, Inc. Chimeric animal model susceptible to human hepatitis C virus infection

Also Published As

Publication number Publication date
US7781642B2 (en) 2010-08-24
KR100656795B1 (ko) 2006-12-12
US7498479B2 (en) 2009-03-03
EP1265480B1 (en) 2010-06-02
NZ521119A (en) 2004-03-26
IL151621A0 (en) 2003-04-10
JP2008022853A (ja) 2008-02-07
US20120309032A1 (en) 2012-12-06
IL151621A (en) 2006-06-11
ATE469547T1 (de) 2010-06-15
US8212106B2 (en) 2012-07-03
US20030115616A1 (en) 2003-06-19
US20110167507A1 (en) 2011-07-07
DE60142281D1 (de) 2010-07-15
EP1265480A1 (en) 2002-12-18
CA2402117A1 (en) 2001-09-20
AU2001242163B2 (en) 2005-06-23
WO2001067854A1 (en) 2001-09-20
AU4216301A (en) 2001-09-24
JP4436389B2 (ja) 2010-03-24
CA2402117C (en) 2012-01-17
KR20030027883A (ko) 2003-04-07
US8445745B2 (en) 2013-05-21
US20070107069A1 (en) 2007-05-10
JP2003526348A (ja) 2003-09-09
US7161057B2 (en) 2007-01-09
JP4059672B2 (ja) 2008-03-12
ES2346636T3 (es) 2010-10-19
US6509514B1 (en) 2003-01-21
US20090151012A1 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
DK1265480T3 (da) Kimærisk forsøgsdyr, der er modtageligt over for infektion med human hepatitis C-virus
ATE401787T1 (de) Menschliches cd20 exprimierende transgene mäuse
DK1600510T3 (da) DNA-sekvenser med antirepressoraktivitet
EA200970233A1 (ru) Кандидатные агенты против инфекций
BRPI0416902A (pt) inibidores de ns3/ns4a serina protease do vìrus da hepatite c
PT1268519E (pt) Inibidores de serina protease, particularmente protease ns3 do virus da hepatite c
MXPA05012788A (es) Analogos de nucleosidos fluorados modificados.
NO20056047L (no) Hepatitt C inhibitor forbindelser
ATE315085T1 (de) Transgene mäuse mit veränderter apolipoprotein e- expression und testverfahren.
CY1110629T1 (el) Πολυθεραπεια για θεραπευτικη αγωγη ιου ηπατιτιδας β
DK1539981T3 (da) Vævsspecifik ekspression af eksogene proteiner i transgene kyllinger
EP3740074A4 (en) PIC1 INHIBITION OF THE OXIDATIVE ACTIVITY OF MYELOPEROXIDASE IN AN ANIMAL MODEL
ATE423574T1 (de) Dominant-negativer plb mutant zur behandlung der herzerkrankungen
ATE517184T1 (de) Hcv ns3/4a kodierende nukleinsäure
EA201200650A1 (ru) Курсы комбинированного лечения вируса гепатита с, включающие bi201335, интерферон-альфа и рибавирин
CY1111654T1 (el) Θεραπευτικη αγωγη πλαγιας μυατροφικης σκληρυνσης
RU2004115107A (ru) Способы профилактики и лечения инфекции, вызываемой флавивирусами у животных
ATE398398T1 (de) Nahrungsmittelzusatz
CY1110788T1 (el) Διαγονιδιακα ζωα τα οποια παρουσιαζουν σημαντικες διαταραχες σχετικες με την νοσο alzheimer
NO20044901L (no) Anvendelse av modifiserte novirhabdoviruser i vaksiner
WO2006023593A3 (en) Malarial animal model having a chimeric human liver
DK1476012T3 (da) Transgene mus, der udtrykker PRKAG3
NO20025898D0 (no) Fremgangsmåte for å öke overlevelsesraten til akvatiske dyr eksponert for en akvatisk virus og sammensetninger til bruk for slikefremgangsmåter
Brass et al. Of mice and men: a small animal model of hepatitis C virus replication
CY1109800T1 (el) Χρηση καρδιοτροφινης σε ηπατικες ασθενειες